The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period January to March 2007 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email
new_accounts@pmlive.com ADVERTISING AGENCIES |
Client | Product | Therapeutic area | Winning agency |
Alliance Pharmaceuticals | Isprelor | Obstetrics and gynaecology | Hanson Zandi |
Healthcare Brands International | Sambucol | Immunology | Woolley Pau |
Merck-Serono | Educational and professional development | Multiple sclerosis | Roundhouse HealthAd |
Merial | Rabisin | Rabies vaccine | Roundhouse HealthAd |
Merz | Xeomin and Belotero | Dermatology | Roundhouse HealthAd |
Roche Products | Herceptin, Avastin | Oncology | MSA Market Media |
Roche Products | Neorecormon | Nephrology | MSA Market Media |
Roche Products | MabThera | Rheumatoid arthritis | MSA Market Media |
Roche Products | Xenical | Obesity | MSA Market Media |
Roche Products | Tamiflu | Influenza | MSA Market Media |
Sanofi Pasteur MSD | Pneumovax II | Pneumococcal vaccine | Woolley Pau |
SD Healthcare | Myiasert | Ophthalmology | Courts Design |
Teva UK | Clozapine | Anti-psychotic | Courts Design |
Wyeth | Anya | Oral contraceptives | Creative Lynx |
Wyeth | DVS - VMS | Menopause | Creative Lynx |
ZLB Behring (Global) | Haemate P | Haematology | Hanson Zandi |
ZLB Behring (Global) | Rhophylac | Obstetrics and gynaecology | Hanson Zandi |
PR AND MED ED |
Client | Product | Therapeutic area | Winning agency |
Alliance Pharmaceuticals | Labour induction website | Obstetrics and gynaecology | Hanson Zandi |
Baxter | Brevibloc | Cardiovascular | Wave Healthcare Communications |
Boehringer Ingelheim | New product | Anti-coagulation | Wave Healthcare Communications |
European Coalition of Positive People | Integrated communications programme | HIV/AIDS and Hepatitis C | De Facto Communications |
Ferring International | Euflexxa KOL development | Orthopaedics | Helen Lawn & Associates |
Ferring International | Zomacton | Endocrinology | Helen Lawn & Associates |
Ferring Pharmaceuticals | DesmoMelt | Urology | Helen Lawn & Associates |
Ferring Pharmaceuticals | VSL 3 | Gastroenterology | Helen Lawn & Associates |
Genzyme | Thyrogen | Endocrinology/oncology | Medaxial |
McNeil | Immodium | Diarrhoea | Spink Consumer Relations |
Merck Pharmaceuticals | Erbitux and Uftoral | Colorectal cancer | Red Door Communications |
Merck-Serono | Easypod | Growth hormone injection device | LeapFrog Medical |
MˆInlycke Healthcare | Patient awareness initiative | Infection control | hsdcommunications |
MSD | New product | HIV | Wave Healthcare Communications |
Nelsons | Rescue remedy | Homeopathy | Pegasus PR |
Novartis | Aclasta | Paget's Disease | LeapFrog Medical |
Novartis | N/A | Cardiovascular, diabetes and neuroscience | Just:: |
sanofi-aventis | N/A | VTE | Medaxial |
Schering Health Care | N/A | Oncology | Medaxial |
Schering Health Care | Zevalin | Oncology | Medaxial |
Shire Pharmaceuticals | Reminyl | Alzheimer's disease | hsdcommunications |
Stiefel Laboratories | Oilatum | Skin conditions | McCann Erickson Communications |